Companies: 10,795·Total market cap: $144.5T
BeyondSpring Inc.

BeyondSpring Inc.

BYSINASDAQHealthcare● Active
$1.70
+$0.00(+0.00%)
Market Cap$69903694
P/E Ratio—
52W High$3.44
52W Low$1.175
Overview
Stock ranking:Biotechnology·Healthcare·View All Market Cap Rankings →

BeyondSpring Inc. (BYSI) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · BYSI · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-0.19bysi eps ttm · bysi earnings per shareEarnings history
PE Ratio (TTM)—bysi pe ratio ttm · bysi price to earningsPE Ratio deep dive
Revenue (TTM)0.00bysi revenue ttm · bysi annual revenueFull revenue history
Dividend YieldNo Dividenddoes bysi pay dividends · bysi dividend yieldDividend history
Shares Outstanding40.4Mbysi shares outstanding · bysi floatShares outstanding history
Next EarningsAug 12, 2026Est.bysi earnings date · bysi next earningsEarnings history

Explore BeyondSpring Inc. Data

bysi stock data · financials
Market Cap$69.9Mbysi market cap · bysi valuation
Analyst Forecast$— · Buy
DividendsNo Dividenddoes beyondspring inc. pay dividends · bysi dividend yield
Revenue—beyondspring inc. annual revenue · bysi revenue
EarningsEPS $-0.20+28.57%bysi earnings · bysi eps
PE Ratio—bysi pe ratio · bysi price to earnings

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
beyondspring inc. revenue · bysi revenue 2025
FY 2025Net Income-$8.0M▲ +28.15% YoY
202320242025
beyondspring inc. net income · bysi profit 2025
FY 2025EPS$-0.20▲ +28.57% YoY
202320242025
bysi eps · beyondspring inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$7.6MEPS: $-0.19View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy9 analystsis bysi a buy · bysi analyst rating
Strong Buy
0
Buy
6
Hold
2
Sell
1
Strong Sell
0
12-Month Price Target
$—Low
$1.70Current
$—Avg Target
$—High
bysi price target · bysi 12 month forecast

Total: 9 · Buy rate: 66.7%

Stock Performance

Full History
1D-0.58%
1W+0.00%
1M+14.09%
3M+17.24%
YTD+4.29%
1Y-23.08%
5Y-85.34%

About BeyondSpring Inc.

CEOLan Huang
IPO DateMar 9, 2017
Employees40
CountryUS
Websitebeyondspringpharma.com

BeyondSpring Inc. is a clinical-stage biopharmaceutical company focused on developing novel cancer treatments. Its flagship product is Plinabulin, a selective immune-modulating and microtubule-binding…

BiotechnologyHealthcareNASDAQUS

what is beyondspring inc. · bysi stock overview · beyondspring inc. company profile · who is beyondspring inc. ceo · bysi NASDAQ · beyondspring inc. headquarters · beyondspring inc. business segments

About Stock Overview & Key Data

BeyondSpring Inc. (BYSI) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Mar 9, 2017. As of the latest trading session, BYSI stock price is $1.70, with a market capitalization of $69.9M. The stock has returned -23.08% over the past 12 months and +4.29% year-to-date.

According to 9 Wall Street analysts, the consensus rating for BeyondSpring Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, BeyondSpring Inc. reported revenue of — and net income of -$8.0M. For detailed data — including BeyondSpring Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, BeyondSpring Inc. (BYSI) stock price is $1.70. The stock is traded on NASDAQ under the ticker symbol BYSI. The 52-week range is $1.18 – $3.44.

BYSI stock priceBYSI quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice